» Articles » PMID: 17332086

Methamphetamine Disposition in Oral Fluid, Plasma, and Urine

Overview
Specialty Science
Date 2007 Mar 3
PMID 17332086
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

This review of the disposition of methamphetamine in oral fluid, plasma, and urine is based on a comprehensive controlled dosing study involving five healthy, drug-free research volunteers who resided on a closed clinical ward for 12 weeks. Subjects were administered four low (10 mg) and high (20 mg) daily oral doses of methamphetamine in two separate sessions. Near-simultaneous collections of oral fluid and plasma were performed on the first day of each low- and high-dose session. Thereafter, oral fluid was provided on each day of dosing by different oral fluid collection methods. All urine specimens were collected on an ad libitum basis throughout the study. Specimens were analyzed by gas-chromatography mass spectrometry for methamphetamine and the metabolite, amphetamine, with a limit of quantification of 2.5 ng/mL for each analyte. Methamphetamine and metabolite concentrations in oral fluid appeared to follow a similar time course in oral fluid as in plasma and were dose-proportional, but oral fluid concentrations exceeded plasma concentrations. Urine drug concentrations were substantially higher than those in oral fluid. Some drug accumulation was noted with daily dosing, but generally did not markedly influence detection times or detection rates of oral fluid tests. Detection times and detection rates for oral fluid and urine were determined at cessation of 4 days of dosing. Generally, detection times and rates for urine were longer than those observed for oral fluid at conventional cutoff concentrations. When contemplating selection of oral fluid as a test matrix, the advantages of oral fluid collection should be weighed against its shorter time of detection compared to that of urine.

Citing Articles

Non-Invasive Point-of-Care Detection of Methamphetamine and Cocaine via Aptamer-Based Lateral Flow Test.

Erkocyigit B, Man E, Efecan E, Ozufuklar O, Devecioglu D, Bagci B Biosensors (Basel). 2025; 15(1).

PMID: 39852082 PMC: 11764150. DOI: 10.3390/bios15010031.


Examining the Relationship between Aptamer Complexity and Molecular Discrimination of a Low-Epitope Target.

Wang L, Canoura J, Byrd C, Nguyen T, Alkhamis O, Ly P ACS Cent Sci. 2024; 10(12):2213-2228.

PMID: 39735321 PMC: 11672540. DOI: 10.1021/acscentsci.4c01377.


Combined Diagnostic Value of Hsa-miR-592 and Hsa-miR-9-3p in Plasma for Methamphetamine Addicts.

Li W, Liu D, Liu X, Lu Y, Zhang L, Yu F Int J Mol Sci. 2024; 25(16).

PMID: 39201637 PMC: 11354292. DOI: 10.3390/ijms25168952.


Methamphetamine dependence in Australia-why is 'ice' (crystal meth) so addictive?.

Scott R Psychiatr Psychol Law. 2024; 31(4):671-704.

PMID: 39118784 PMC: 11305059. DOI: 10.1080/13218719.2023.2206870.


A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial.

McKetin R, Degan T, Saunders L, Nguyen L, Dore G, Shoptaw S Trials. 2024; 25(1):408.

PMID: 38907288 PMC: 11193254. DOI: 10.1186/s13063-024-08238-y.


References
1.
Oyler J, Cone E, Joseph Jr R, Moolchan E, Huestis M . Duration of detectable methamphetamine and amphetamine excretion in urine after controlled oral administration of methamphetamine to humans. Clin Chem. 2002; 48(10):1703-14. View

2.
BECKETT A, Salmon J, Mitchard M . The relation between blood levels and urinary excretion of amphetamine under controlled acidic and under fluctuating urinary pH values using [14C] amphetamine. J Pharm Pharmacol. 1969; 21(4):251-8. DOI: 10.1111/j.2042-7158.1969.tb08241.x. View

3.
Kim I, Oyler J, Moolchan E, Cone E, Huestis M . Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans. Ther Drug Monit. 2004; 26(6):664-72. DOI: 10.1097/00007691-200412000-00013. View

4.
Schepers R, Oyler J, Joseph Jr R, Cone E, Moolchan E, Huestis M . Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem. 2003; 49(1):121-32. DOI: 10.1373/49.1.121. View

5.
Maxwell J . Emerging research on methamphetamine. Curr Opin Psychiatry. 2006; 18(3):235-42. DOI: 10.1097/01.yco.0000165592.52811.84. View